Table 4.
Prescribers’ reports of additional unsupervised doses.
| methadone prescribers | buprenorphine prescribers | SROM prescribers | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| I decreased the frequency of unsupervised doses for patients | 26 (30%) | 15 (18%) | 5 (12%) |
| I prescribed unsupervised doses for patients who previously were not prescribed any unsupervised doses | 58 (67%) | 59 (71%) | 21 (50%) |
| I increased the frequency of unsupervised doses prescribed in patients who had some weekly unsupervised doses | 60 (70%) | 67 (81%) | 15 (36%) |
| I allowed unsupervised doses for patients where I was unsure about their social or housing stability | 18 (21%) | 21 (25%) | 12 (29%) |
| I prescribed unsupervised doses only in situations where I felt their social and housing situations were stable | 52 (61%) | 51 (61%) | 13 (31%) |
| Total # prescribers | 86 | 83 | 42 |
Note: SROM = Slow release oral morphine; Prescribers were asked to note each type of OAT that they prescribe and to select each statement that applied to the type(s) of OAT they prescribe.